Blue Pool Capital

Artifact Labs is a leading Web3 and NFT company.

The Premier Lacrosse League (PLL) is a professional lacrosse organization in North America that aims to elevate the sport to a national stage through a tour-based model. By featuring top players and teams, the PLL seeks to engage fans and enhance the entertainment value of lacrosse. The league is recognized for its innovative approach, focusing on fan experience and accessibility, which positions it as a leader in promoting the fastest-growing sport in the country. Through its unique format and commitment to showcasing elite talent, the PLL is pioneering a new future for lacrosse.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated, genomically-enabled drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine aims to elucidate human biology and develop innovative therapeutics that target the underlying causes of serious diseases. By mining fungal biodiversity, the company seeks to create novel therapeutics designed to tackle previously intractable medical challenges, ultimately enhancing treatment options for healthcare providers.

Fanatics, Inc. is a leading vertical commerce company specializing in the design, manufacture, distribution, and retail of licensed sports merchandise on a global scale. Founded in 1995 and headquartered in Jacksonville, Florida, with additional offices in San Mateo, California, and Manchester, United Kingdom, Fanatics offers a wide range of sports apparel through its online platforms, mobile applications, and physical stores. The company features an extensive product assortment, including over 120,000 items related to various sports leagues such as the NFL, MLB, NBA, NCAA, NASCAR, and NHL. Fanatics also provides outsourced e-commerce solutions through its TeamFanShop division, which operates the official online stores for numerous prominent sports organizations. This multi-channel approach allows Fanatics to effectively meet the evolving demands of fans and retailers in today's fast-paced, on-demand marketplace.

Aver is a decentralized peer-to-peer betting exchange built on the Solana blockchain and the world’s first decentralized Web3 betting exchange.

Animoca Brands is a digital entertainment company that specializes in leveraging gamification, blockchain, and artificial intelligence technologies to develop and publish a diverse range of mobile products globally. The company is known for its popular games, including The Sandbox, Crazy Kings, and Crazy Defense Heroes, as well as titles based on well-known intellectual properties such as Formula 1, Marvel, Garfield, and Doraemon. Additionally, Animoca Brands supports the implementation of Web3.0 strategies for intellectual property holders, providing a platform that enables the creation of non-fungible tokens (NFTs) and fungible tokens. This platform allows IP holders, including brands and artists, to monetize their rights and build fan communities within the blockchain ecosystem. With a strong portfolio of blockchain investments and partnerships, Animoca Brands aims to enhance user experiences and facilitate the trading of digital property rights. The company operates across multiple locations, including Australia, Hong Kong, South Korea, Finland, and Argentina.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated, genomically-enabled drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine aims to elucidate human biology and develop innovative therapeutics that target the underlying causes of serious diseases. By mining fungal biodiversity, the company seeks to create novel therapeutics designed to tackle previously intractable medical challenges, ultimately enhancing treatment options for healthcare providers.

FogPharma is a healthcare company founded in 2015 and headquartered in Gloucester, Massachusetts. The firm is dedicated to the pharmaceutical sector, with a primary focus on developing innovative treatments for cancer. It operates with the support of a diverse group of private and institutional investors, fostering collaboration among its founders, employees, and advisors. FogPharma aims to create a new class of medicines designed to extend and enhance the lives of cancer patients. The company's commitment to its mission drives its efforts to pioneer effective solutions in cancer treatment.

PlayVS is an operator of an eSports platform used to organize competitions in eSports on behalf of high school. Its platform offers to organize online tournaments and wagers for cash and prizes and helps to play and stay up-to-date on high school e-sports programs that enable teen gamers to form teams at their high schools to compete with players from other schools and the battle for titles at state championships.

Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.

Grail, Inc. is a healthcare company dedicated to developing innovative technologies for early cancer detection. Founded in 2015 and based in Menlo Park, California, the company has created Galleri, a blood test designed for asymptomatic individuals over 50 years old, which identifies various types of cancer at early stages. In addition to Galleri, Grail is developing a diagnostic aid called DAC to accelerate the diagnostic process for patients with a clinical suspicion of cancer. The company is also working on tests for minimal residual disease and other post-diagnostic applications. Through high-intensity sequencing and population-scale clinical trials, Grail aims to advance the field of cancer screening and improve patient outcomes.

FogPharma is a healthcare company founded in 2015 and headquartered in Gloucester, Massachusetts. The firm is dedicated to the pharmaceutical sector, with a primary focus on developing innovative treatments for cancer. It operates with the support of a diverse group of private and institutional investors, fostering collaboration among its founders, employees, and advisors. FogPharma aims to create a new class of medicines designed to extend and enhance the lives of cancer patients. The company's commitment to its mission drives its efforts to pioneer effective solutions in cancer treatment.

Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXi Ventures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.

Rent the Runway is an e-commerce platform that enables women to rent, subscribe, or purchase designer apparel and accessories. Founded in 2008 and based in New York, the company offers a diverse selection of items including party dresses, gowns, jumpsuits, outerwear, and various accessories such as jewelry and handbags. Rent the Runway has transformed the fashion landscape by promoting the concept of renting over buying, aiming to make fashion more accessible and sustainable. The platform features options for different occasions, including work and special events, and operates through a subscription service, allowing users to access a "closet in the cloud." With partnerships with over 550 designers and a user base exceeding eight million, Rent the Runway employs approximately 1,200 people, with a significant proportion being women and minorities. The company has also established the Rent the Runway Foundation to support female entrepreneurs in their business endeavors.

LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated, genomically-enabled drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine aims to elucidate human biology and develop innovative therapeutics that target the underlying causes of serious diseases. By mining fungal biodiversity, the company seeks to create novel therapeutics designed to tackle previously intractable medical challenges, ultimately enhancing treatment options for healthcare providers.

Lytro, founded in 2006 by Ren Ng, specializes in Light Field imaging technology, providing a platform that allows artists, scientists, and innovators to capture multi-dimensional data from various angles. The company launched its first consumer Light Field camera in 2012, followed by the second-generation Lytro ILLUM in 2014, along with accompanying software tools to enhance user experience. By 2015, Lytro expanded its focus to include cinematography, virtual reality, and scientific applications, establishing itself as a key player in a new technological ecosystem. This strategic shift aimed to extend the capabilities of Light Field imaging across diverse industries, granting users unprecedented creative freedom and visual quality. Headquartered in Mountain View, California, Lytro is supported by prominent venture capital firms.